Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01672 ASCLETIS-B
RTNominal up1.290 +0.020 (+1.575%)
Others

18/10/2019 15:38

Ascletis (01672) controlling shareholders buy more shares

[ET Net News Agency, 18 October 2019] Ascletis Pharma Inc. (01672) said it was informed
by the executive directors and controlling shareholders of the company, Dr Jinzi Jason Wu
and Mrs Judy Hejingdao Wu, that they have jointly purchased in aggregate of 2.31 million
shares of the company on the open market for an aggregate consideration of HK$6.99 million
(representing an average price of HK$3.02 per share).
Immediately following the Purchase, they are interested in an aggregate of 599.53
million shares (before the purchase: 597.22 million shares), representing approximately
53.50% (before the purchase: 53.29%) of the total issued share capital of the company.
(RC)

Back to Others

Remark: Real time quote last updated: 19/04/2024 14:12
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.